Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;2(4):523-36.
doi: 10.4155/tde.11.20.

Polymeric vectors for ocular gene delivery

Affiliations
Review

Polymeric vectors for ocular gene delivery

Viral Tamboli et al. Ther Deliv. 2011 Apr.

Abstract

Gene therapy holds promise for the treatment of many inherited and acquired diseases of the eye. Successful ocular gene therapy interventions depend on efficient gene transfer to targeted cells with minimal toxicity. A major challenge is to overcome both intracellular and extracellular barriers associated with ocular gene delivery. Numerous viral and nonviral vectors were explored to improve transfection efficiency. Among nonviral delivery systems, polymeric vectors have gained significant attention in recent years owing to their nontoxic and non-immunogenic nature. Polyplexes or nanoparticles can be prepared by interaction of cationic polymers with DNA, which facilitate cellular uptake, endolysosomal escape and nuclear entry through active mechanisms. Chemical modification of these polymers allows for the generation of flexible delivery vectors with desirable properties. In this article several synthetic and natural polymeric systems utilized for ocular gene delivery are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Eye structure.
Figure 2
Figure 2. Ocular barriers
(A) Corneal barrier; (B) BRB. BRB: Blood–retinal barrier.
Figure 3
Figure 3
Polymers utilized in ocular gene delivery.

Similar articles

Cited by

References

    1. Wu TL, Ertl HC. Immune barriers to successful gene therapy. Trends Mol Med. 2009;15:32–39. - PubMed
    1. Chaum E, Hatton MP. Gene therapy for genetic and acquired retinal diseases. Surv Ophthalmol. 2002;47:449–469. - PubMed
    1. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE. Gene therapy in the cornea. Prog Retin Eye Res. 2005;24:537–559. - PubMed
    1. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92–95. - PubMed
    1. Acland GM, Aguirre GD, Bennett J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12:1072–1082. - PMC - PubMed

Publication types

MeSH terms